The two-dose inactivated EV71 vaccine provides durable protection exceeding 72% against hand, foot, and mouth disease for at least 20 years in children.
Does a two-dose regimen of the inactivated EV71 vaccine provide long-term protection against hand, foot, and mouth diseases in children?
A two-dose inactivated EV71 vaccine is modelled to provide >72% protection against hand, foot, and mouth disease for at least 20 years in China.
Absolute Event Rate: 0% vs 0%
Under the current EV71 epidemic conditions in China, the two-dose regimen of the inactivated EV71 vaccine provides durable protection exceeding 72% for at least 20 years.
Ma et al. (Thu,) reported a other. The two-dose inactivated EV71 vaccine provides durable protection exceeding 72% against hand, foot, and mouth disease for at least 20 years in children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: